Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0HCDDL
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Glaucoma therapy
|
|||||
| Synonyms |
Glaucoma therapy (Houston)
Click to Show/Hide
|
|||||
| Organization |
Houston Biotechnology, Inc.; Bristol Myers Squibb Co.
|
|||||
| Drug Status |
Investigative
|
|||||
| Antibody Name |
Undisclosed
|
Antigen Name |
Undisclosed
|
|||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||